| Glenmark Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.03 | 0.10 | 0.20 | 0.24 | 0.26 |
| Long Term Debt-Equity Ratio | 0.00 | 0.07 | 0.15 | 0.18 | 0.22 |
| Current Ratio | 1.25 | 1.27 | 1.48 | 1.80 | 2.12 |
| Fixed Assets | 2.59 | 2.40 | 2.65 | 2.77 | 2.78 |
| Inventory | 7.35 | 7.07 | 8.05 | 9.50 | 9.46 |
| Debtors | 3.67 | 3.16 | 3.17 | 3.15 | 3.50 |
| Interest Cover Ratio | 45.20 | 7.97 | 10.97 | 9.08 | 8.31 |
| PBIDTM (%) | 26.24 | 30.54 | 29.84 | 28.29 | 31.19 |
| PBITM (%) | 23.87 | 27.98 | 27.60 | 26.33 | 29.20 |
| PBDTM (%) | 25.72 | 27.03 | 27.32 | 25.40 | 27.68 |
| CPM (%) | 19.82 | 20.62 | 21.44 | 22.15 | 23.79 |
| APATM (%) | 17.45 | 18.06 | 19.20 | 20.19 | 21.80 |
| ROCE (%) | 8.94 | 9.75 | 10.79 | 10.93 | 12.39 |
| RONW (%) | 6.78 | 6.98 | 9.12 | 10.42 | 11.77 |